Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2084118 | European Journal of Pharmaceutics and Biopharmaceutics | 2011 | 7 Pages |
The effectiveness of α-glucosyl hesperidin (Hsp-G) as a novel grinding aid for the preparation of drug nanoparticles by dry grinding was investigated. Poorly water-soluble drugs and Hsp-G were mixed at a weight ratio of 1/5 and ground for 60 min by a vibrational ball mill. It was evident that all poorly water-soluble drugs used in this study formed nanoparticles after the ground mixtures were dispersed into distilled water. The dissolution profile of glibenclamide from the ground mixtures of glibenclamide/Hsp-G showed dramatic improvement from that of untreated drug crystals. Administration of the ground mixture of glibenclamide/Hsp-G to rats resulted in a significantly higher rate of decrease in blood glucose levels than that of untreated glibenclamide. The area above the time-curve of plasma-glucose concentrations using the ground mixture of glibenclamide/Hsp-G was 6-fold higher than that using untreated glibenclamide. The improved dissolution rate due to nanoparticle formation of glibenclamide, induced by co-grinding with Hsp-G, was responsible for this improvement.
Graphical abstractNanoparticle formation of glibenclamide, induced by co-grinding with alpha-glucosyl hesperidin, resulted in a significantly higher rate of decrease in blood glucose level than that of untreated glibenclamide.Figure optionsDownload full-size imageDownload as PowerPoint slide